Abstract
Vitamin K antagonists (VKAs) are the standard of care for stroke prevention in patients with atrial fibrillation (AF); therefore, there is not equipoise when comparing newer oral anticoagulants with placebo in this setting. To explore the effect of apixaban on mortality in patients with AF, we performed a meta-analysis of apixaban versus placebo using a putative placebo analysis based on randomized controlled clinical trials that compared warfarin, aspirin, and no antithrombotic control. We used data from two prospective randomized controlled trials for our comparison of apixaban versus warfarin (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) and apixaban versus aspirin (Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment). Using meta-analysis approaches, we indirectly compared apixaban with an imputed placebo with respect to the risk of death in patients with AF. We used results from meta-analyses of randomized trials as our reference for the comparison between warfarin and placebo/no treatment, and aspirin and placebo/no treatment. In these meta-analyses, a lower rate of death was s...Continue Reading
References
Jun 1, 1997·Journal of Clinical Epidemiology·H C BucherS D Walter
Sep 16, 1998·Circulation·E J BenjaminD Levy
Jan 3, 2001·American Heart Journal·L D FisherH R Büller
Jan 12, 2002·BMJ : British Medical Journal·UNKNOWN Antithrombotic Trialists' Collaboration
Feb 20, 2002·Controlled Clinical Trials·Sue-Jane WangYi Tsong
Mar 11, 2003·Statistics in Medicine·Sylvain Durrleman, Philip Chaikin
Mar 31, 2004·Circulation·Jonathan S SteinbergH Leon Greene
Jun 20, 2007·Annals of Internal Medicine·Robert G HartMaria I Aguilar
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Aug 6, 2010·European Heart Journal·Deirdre A Lane, Gregory Y H Lip
Feb 12, 2011·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN AVERROES Steering Committee and Investigators
May 26, 2011·JAMA : the Journal of the American Medical Association·David ConenChristine M Albert
Jul 13, 2011·Journal of Neurology·Alvaro CerveraAngel Chamorro
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Apr 12, 2012·Stroke; a Journal of Cerebral Circulation·Robert G HartSalim Yusuf
Sep 11, 2013·Circulation·Eloi MarijonUNKNOWN RE-LY Investigators
Nov 21, 2013·The New England Journal of Medicine·Robert P GiuglianoUNKNOWN ENGAGE AF-TIMI 48 Investigators
Nov 28, 2013·European Heart Journal·Jonathan P PicciniSusan R Heckbert
Dec 10, 2013·Lancet·Christian T RuffElliott M Antman
Apr 20, 2014·Stroke; a Journal of Cerebral Circulation·Graeme J HankeyUNKNOWN ROCKET AF Steering Committee and Investigators
Nov 25, 2014·European Heart Journal·John McMurrayUNKNOWN PARADIGM-HF Committees and Investigators
Mar 10, 2016·Journal of the American Heart Association·Sean D PokorneyUNKNOWN ROCKET AF Steering Committee Investigators
Mar 31, 2017·Blood·Renato D LopesHans-Christoph Diener